nach oben

Erschienen in:

01.07.2023 | Sleep Breathing Physiology and Disorders • Original Article

Association between hypoxic burden and common cardiometabolic diseases in patients with severe obstructive sleep apnea

verfasst von: Maythad Uataya, Wish Banhiran, Wattanachai Chotinaiwattarakul, Phawin Keskool, Sarin Rungmanee, Chawanont Pimolsri

Erschienen in: Sleep and Breathing | Ausgabe 6/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To determine the possible associations between total sleep time spent with arterial oxygen saturation < 90% (T90) and comorbid cardiometabolic diseases (CMDs) in patients with severe obstructive sleep apnea (OSA).

Methods

A retrospective review of the chart was conducted in patients with severe OSA diagnosed by in-lab polysomnography (PSG) between January 2018 and December 2019 at Siriraj Hospital. The patients were divided into two groups: hypoxic (T90 ≥ 10%) and nonhypoxic (T90 < 10%). The association between common CMDs including hypertension (HT), type 2 diabetes mellitus (T2DM), and impaired fasting glucose (IFG) was investigated and compared between the two groups.

Results

Data were collected from 450 patients with severe OSA, 289 males/161 females with a mean age of 53.5 ± 14.2 years and an apnea-hypopnea index (AHI) of 49.6 events/h. Among these, 114 patients (25.3%) were defined as the hypoxic group (T90 ≥ 10%). When compared between the hypoxic and nonhypoxic groups, the patients in the hypoxic group were significantly younger and more obese, and had a higher proportion of male patients. The majority of patients (80%) had at least one CMD; however, the most common comorbidities significantly associated with hypoxic OSA (T90 ≥ 10%) were HT and IFG.

Conclusion

Hypoxic burden is significantly associated with an increased prevalence of HT and IFG in patients with severe OSA. T90 may be potentially useful for predicting CMDs in these patients. However, prospective studies are still required.

Fallahi A, Jamil DI, Karimi EB, Baghi V, Gheshlagh RG (2019) Prevalence of obstructive sleep apnea in patients with type 2 diabetes: a systematic review and meta-analysis. Diabetes Metab Syndr 13(4):2463–2468CrossRefPubMed

Lam JC, Mak JC, Ip MS (2012) Obesity, obstructive sleep apnoea and metabolic syndrome. Respirology. 17(2):223–236CrossRefPubMed

Dhakal SS, Neupane A, Bhattarai M, Karki DB (2020) Prevalence of atrial fibrillation in obstructive sleep apnea patients in a tertiary care center. JNMA J Nepal Med Assoc 58(222):80–83PubMedPubMedCentral

Sterz U, Buchner S, Hetzenecker A, Satzl A, Debl K, Luchner A et al (2018) Erratum to: resolution of ST deviation after myocardial infarction in patients with and without sleep-disordered breathing. Somnologie (Berl) 22(2):130CrossRefPubMed

Qaseem A, Dallas P, Owens DK, Starkey M, Holty JE, Shekelle P et al (2014) Diagnosis of obstructive sleep apnea in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med 161(3):210–220CrossRefPubMed

Bailly S, Destors M, Grillet Y, Richard P, Stach B, Vivodtzev I et al (2016) Obstructive sleep apnea: a cluster analysis at time of diagnosis. PloS One 11(6):e0157318CrossRefPubMedPubMedCentral

Punjabi NM (2016) COUNTERPOINT: is the apnea-hypopnea index the best way to quantify the severity of sleep-disordered breathing? No. Chest 149(1):16–19CrossRefPubMed

Azarbarzin A, Sands SA, Taranto-Montemurro L, Vena D, Sofer T, Kim SW et al (2020) The sleep apnea-specific hypoxic burden predicts incident heart failure. Chest. 158(2):739–750CrossRefPubMedPubMedCentral

Azarbarzin A, Sands SA, Stone KL, Taranto-Montemurro L, Messineo L, Terrill PI et al (2019) The hypoxic burden of sleep apnoea predicts cardiovascular disease-related mortality: the Osteoporotic Fractures in Men Study and the Sleep Heart Health Study. Eur Heart J 40(14):1149–1157CrossRefPubMed

10.

Thomas RJ, Weiss MD, Mietus JE, Peng CK, Goldberger AL, Gottlieb DJ (2009) Prevalent hypertension and stroke in the Sleep Heart Health Study: association with an ECG-derived spectrographic marker of cardiopulmonary coupling. Sleep. 32(7):897–904PubMedPubMedCentral

11.

Almendros I, Basoglu OK, Conde SV, Liguori C, Saaresranta T (2022) Metabolic dysfunction in OSA: is there something new under the sun? J Sleep Res 31(1):e13418CrossRefPubMed

12.

Akashiba T, Inoue Y, Uchimura N, Ohi M, Kasai T, Kawana F et al (2022) Sleep apnea syndrome (SAS) clinical practice guidelines 2020. Respir Investig 60(1):3–32CrossRefPubMed

13.

Patil SP, Ayappa IA, Caples SM, Kimoff RJ, Patel SR, Harrod CG (2019) Treatment of adult obstructive sleep apnea with positive airway pressure: an American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med 15(2):335–343CrossRefPubMedPubMedCentral

14.

Labarca G, Campos J, Thibaut K, Dreyse J, Jorquera J (2019) Do T90 and SaO2 nadir identify a different phenotype in obstructive sleep apnea? Sleep Breath 23(3):1007–1010CrossRefPubMed

15.

Labarca G, Dreyse J, Salas C, Letelier F, Schmidt A, Rivera F et al (2020) Clinical utility of oximetric parameters to identify a high-risk phenotype of moderate-severe obstructive sleep apnea (OSA). Clin Respir J 14(12):1166–1175CrossRefPubMed

16.

Andre S, Andreozzi F, Van Overstraeten C, Ben Youssef S, Bold I, Carlier S et al (2020) Cardiometabolic comorbidities in obstructive sleep apnea patients are related to disease severity, nocturnal hypoxemia, and decreased sleep quality. Respir Res 21(1):35CrossRefPubMedPubMedCentral

17.

Brown LK (2007) Mild obstructive sleep apnea syndrome should be treated. Pro J Clin Sleep Med 3(3):259–262CrossRefPubMed

18.

Silva LOE, Guimaraes TM, Luz GP, Coelho G, Badke L, Almeida IR et al (2018) Metabolic profile in patients with mild obstructive sleep apnea. Metab Syndr Relat Disord 16(1):6–12CrossRefPubMed

19.

Martinez-Garcia MA, Campos-Rodriguez F, Barbe F, Gozal D, Agusti A (2019) Precision medicine in obstructive sleep apnoea. Lancet Respir Med 7(5):456–464CrossRefPubMed

20.

Chen F, Chen K, Zhang C, Chen X, Huang J, Jia P et al (2018) Evaluating the clinical value of the hypoxia burden index in patients with obstructive sleep apnea. Postgrad Med 130(4):436–441CrossRefPubMed

21.

Venkatnarayan K, Krishnaswamy UM, Rajamuri NKR, Selvam S, Veluthat C, Devaraj U, Ramachandran P, D'Souza G (2022) Identifying phenotypes of obstructive sleep apnea using cluster analysis. Sleep Breath. https://doi.org/10.1007/s11325-022-02683-2

22.

Lin CM, Davidson TM, Ancoli-Israel S (2008) Gender differences in obstructive sleep apnea and treatment implications. Sleep Med Rev 12(6):481–496CrossRefPubMedPubMedCentral

23.

Quan W, Zheng D, Douglas McEvoy R, Barbe F, Chen R, Liu Z et al (2018) High risk characteristics for recurrent cardiovascular events among patients with obstructive sleep apnoea in the SAVE study. EClinicalMedicine. 2-3:59–65CrossRefPubMedPubMedCentral

24.

Emerging Risk Factors C, Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S et al (2010) Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 375(9733):2215–2222CrossRef

25.

Muraki I, Wada H, Tanigawa T (2018) Sleep apnea and type 2 diabetes. J Diabetes Investig 9(5):991–997CrossRefPubMedPubMedCentral

26.

Nagayoshi M, Punjabi NM, Selvin E, Pankow JS, Shahar E, Iso H et al (2016) Obstructive sleep apnea and incident type 2 diabetes. Sleep Med 25:156–161CrossRefPubMedPubMedCentral

27.

Olea E, Agapito MT, Gallego-Martin T, Rocher A, Gomez-Nino A, Obeso A et al (2014) Intermittent hypoxia and diet-induced obesity: effects on oxidative status, sympathetic tone, plasma glucose and insulin levels, and arterial pressure. J Appl Physiol (1985) 117(7):706–719CrossRefPubMed

28.

Fagan KA, Fouty BW, Tyler RC, Morris KG Jr, Hepler LK, Sato K et al (1999) The pulmonary circulation of homozygous or heterozygous eNOS-null mice is hyperresponsive to mild hypoxia. J Clin Invest 103(2):291–299CrossRefPubMedPubMedCentral

29.

Linz D, Loffler KA, Sanders P, Catcheside P, Anderson CS, Zheng D et al (2020) Low prognostic value of novel nocturnal metrics in patients with OSA and high cardiovascular event risk: post hoc analyses of the SAVE study. Chest. 158(6):2621–2631CrossRefPubMedPubMedCentral

30.

Rahangdale S, Yeh SY, Novack V, Stevenson K, Barnard MR, Furman MI et al (2011) The influence of intermittent hypoxemia on platelet activation in obese patients with obstructive sleep apnea. J Clin Sleep Med 7(2):172–178CrossRefPubMedPubMedCentral

Titel: Association between hypoxic burden and common cardiometabolic diseases in patients with severe obstructive sleep apnea
verfasst von: Maythad Uataya
Wish Banhiran
Wattanachai Chotinaiwattarakul
Phawin Keskool
Sarin Rungmanee
Chawanont Pimolsri
Publikationsdatum: 01.07.2023
Verlag: Springer International Publishing
Erschienen in: Sleep and Breathing / Ausgabe 6/2023
Print ISSN: 1520-9512
Elektronische ISSN: 1522-1709
DOI: https://doi.org/10.1007/s11325-023-02860-x

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Association between hypoxic burden and common cardiometabolic diseases in patients with severe obstructive sleep apnea